CORT vs TMUS · P/E 199, rev $421.1M vs P/E 19, rev $22.79B
Corcept Therapeutics Incorporated (CORT) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the CORT and TMUS stock pages for the full models.
Not investment advice.